by Team Small News | Sep 3, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Eribulin Mesylate Injection, 1mg/2mL (0.5 mg/mL) Single-Dose Vials. The product is bioequivalent and therapeutically equivalent to the reference listed drug, Halaven Injection, 1 mg/2 mL (0.5...
by Team Small News | Sep 3, 2025 | Pharma, Zydus
The global market for seasonal influenza vaccines is expected to experience significant growth, with a projected value of $24.1 billion by 2035, up from $10.2 billion in 2025, at a compound annual growth rate (CAGR) of 9%. Major multinational vaccine manufacturers,... by Team Small News | Sep 2, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has made a significant breakthrough in the US market by launching the first complex generic cancer drug, Fulvestrant Injection, 250 mg/5 mL (50 mg/mL). This is a generic version of Faslodex, an injectable medication used to treat hormone...
by Team Small News | Sep 2, 2025 | Pharma, Sun Pharma, Torrent Pharma, Zydus
Gujarat is playing a vital role in India’s pharmaceutical industry, driven by government initiatives and investment opportunities. The state is home to major pharmaceutical companies such as Sun Pharma, Zydus Cadila, and Intas Pharmaceuticals, contributing... by Team Small News | Sep 1, 2025 | Pfizer, Pharma
Pfizer has submitted an application to the US Food and Drug Administration (FDA) to approve the use of its COVID-19 vaccine in children aged 5-11. This age group is currently not eligible for the vaccine, which is only authorized for individuals 12 years and older.... by Team Small News | Sep 1, 2025 | Fortis, Pharma
Fortis Hospital, Mohali, recently hosted the zonal finals of the 8th edition of its national psychology quiz program, “PSYCH-ED, 2025”. The event saw participation from over 900 schools across India, with more than 12,000 students from 190+ cities taking...